MaxCyte Signs Strategic Platform License with Be Biopharma : vimarsana.com

Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs...

Related Keywords

United Kingdom , Anya Bolshem , Chris Welsh , Maher Masoud , David Deuchler , Bio Bcms , Richard James , Panmure Gordon , Mary Jane Elliott , Emma Earl Freddy Crossley , Rupert Dearden , David Rawlings , Seattle Children Research Institute , Nasdaq , Bristol Myers Squibb , Maxcyte Inc , Twitter , Longwood Fund , Gilmartin Group , Linkedin , Atlas Venture , Engineeredb Cell Medicines , Seattle Children , Alta Partners , Takeda Ventures , Research Institute , Cyte Contacts , Joint Corporate , Bio Contacts , Nasdaq Mxct , Axcyte , Nc ,